Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea.
BACKGROUND: As part of the ring vaccination trial in Guinea, Front Line Workers were invited to participate in a sub-study to provide additional information on the immunogenicity and safety of rVSVΔG/ZEBOV-GP.